Total Payments
$1,580
2024 Payments
$141.88
Companies
22
Transactions
93
Medicare Patients
3,735
Medicare Billing
$234,485
Payment Breakdown by Category
Food & Beverage$1,560 (98.7%)
Education$20.16 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,560 | 90 | 98.7% |
| Education | $20.16 | 3 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $477.45 | 26 | $0 (2021) |
| ABBVIE INC. | $198.72 | 15 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $105.10 | 5 | $0 (2022) |
| Novo Nordisk Inc | $91.08 | 5 | $0 (2024) |
| Lilly USA, LLC | $76.71 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $75.59 | 4 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $74.82 | 5 | $0 (2021) |
| Exact Sciences Corporation | $63.96 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $61.61 | 3 | $0 (2023) |
| PFIZER INC. | $56.63 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $141.88 | 8 | E.R. Squibb & Sons, L.L.C. ($32.41) |
| 2023 | $204.71 | 9 | Lilly USA, LLC ($55.80) |
| 2022 | $87.18 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($61.34) |
| 2021 | $347.45 | 24 | AbbVie Inc. ($144.65) |
| 2020 | $588.21 | 34 | Amarin Pharma Inc. ($459.13) |
| 2019 | $144.92 | 9 | Astellas Pharma US Inc ($37.81) |
| 2018 | $65.75 | 5 | Janssen Pharmaceuticals, Inc ($17.02) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Oncology | ||||||
| 12/09/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.87 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.47 | General |
| 07/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.54 | General |
| Category: Cardiovascular | ||||||
| 04/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Oncology | ||||||
| 10/26/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Diabetes | ||||||
| 10/19/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Oncology | ||||||
| 05/16/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Oncology | ||||||
| 05/12/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: Diabetes | ||||||
| 05/10/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Diabetes | ||||||
| 03/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $37.20 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Cardio-renal | ||||||
| 11/02/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: DIABETES | ||||||
| 08/10/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.40 | General |
| Category: DIABETES | ||||||
| 07/06/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/27/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, SYNJARDY | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: DIABETES | ||||||
| 10/14/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 845 | 1,132 | $245,408 | $47,367 |
| 2022 | 20 | 1,081 | 1,388 | $180,313 | $61,872 |
| 2021 | 14 | 865 | 1,170 | $137,958 | $65,230 |
| 2020 | 14 | 944 | 1,265 | $137,194 | $60,016 |
Total Patients
3,735
Total Services
4,955
Medicare Billing
$234,485
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 194 | 410 | $138,375 | $23,405 | 16.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 134 | 134 | $46,190 | $7,575 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 149 | $35,671 | $5,752 | 16.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 30 | 30 | $2,400 | $2,274 | 94.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $5,481 | $2,063 | 37.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 107 | 107 | $4,911 | $2,039 | 41.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 84 | 84 | $3,931 | $1,616 | 41.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 36 | 36 | $1,652 | $1,133 | 68.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 17 | 20 | $2,646 | $620.80 | 23.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 33 | 57 | $2,280 | $508.60 | 22.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 44 | 57 | $1,140 | $188.39 | 16.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 17 | 17 | $510.00 | $103.87 | 20.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 17 | 17 | $221.00 | $86.36 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 392 | $78,569 | $23,440 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 176 | 245 | $34,361 | $11,131 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 126 | 126 | $24,438 | $8,446 | 34.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 39 | $10,465 | $3,530 | 33.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 35 | 35 | $2,615 | $2,451 | 93.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 83 | 85 | $9,910 | $2,431 | 24.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 16 | 18 | $5,585 | $2,031 | 36.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 94 | 94 | $2,547 | $1,800 | 70.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 12 | $3,132 | $1,527 | 48.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $1,280 | $1,272 | 99.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 38 | 38 | $1,257 | $993.24 | 79.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 36 | 56 | $1,340 | $537.41 | 40.1% |
About Thomas Gray
Thomas Gray is a Family Medicine healthcare provider based in Hillsboro, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2012. The National Provider Identifier (NPI) number assigned to this provider is 1174898373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thomas Gray has received a total of $1,580 in payments from pharmaceutical and medical device companies, with $141.88 received in 2024. These payments were reported across 93 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,560).
As a Medicare-enrolled provider, Gray has provided services to 3,735 Medicare beneficiaries, totaling 4,955 services with total Medicare billing of $234,485. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Hillsboro, OR
- Active Since 03/21/2012
- Last Updated 02/14/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174898373
Products in Payments
- Vascepa (Drug) $477.45
- JARDIANCE (Drug) $114.61
- UBRELVY (Drug) $104.57
- MYRBETRIQ (Drug) $75.59
- QULIPTA (Drug) $75.35
- Cologuard Collection Kit (Device) $63.96
- TRELEGY ELLIPTA (Drug) $61.61
- Aimovig (Biological) $45.38
- XARELTO (Drug) $45.32
- ELIQUIS (Drug) $44.08
- MOUNJARO (Drug) $42.91
- Rybelsus (Drug) $42.17
- KRYSTEXXA (Biological) $32.57
- INVOKANA (Drug) $29.50
- FARXIGA (Drug) $27.27
- Ozempic (Drug) $26.86
- Strensiq (Drug) $26.41
- CHANTIX (Drug) $25.85
- TRADJENTA (Drug) $24.29
- Saxenda (Drug) $22.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hillsboro
Dr. David Stansfield, Do, DO
Family Medicine — Payments: $10,120
Family Medicine $10,120
Dr. Danielle Shapiro, Md, MD
Family Medicine — Payments: $6,386
Family Medicine $6,386
Jacob Yankowitz, Do, DO
Family Medicine — Payments: $4,506
Family Medicine $4,506
Traci Ackron, D.o, D.O
Family Medicine — Payments: $3,715
Family Medicine $3,715
Timothy Luithle, Md, MD
Family Medicine — Payments: $2,472
Family Medicine $2,472
Dr. Matthew Studebaker, M.d, M.D
Family Medicine — Payments: $2,463
Family Medicine $2,463